Jatin Choudhary
YOU?
Author Swipe
View article: TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis
TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis Open
Objective There are limited data on the utility of TAS-102 plus bevacizumab in patients with chemotherapy-refractory metastatic colorectal cancer (mCRC) treated in India. Methods Patients diagnosed with chemotherapy-refractory mCRC, define…
View article: Early-life gut inflammation drives sex-dependent shifts in the microbiome-endocrine-brain axis
Early-life gut inflammation drives sex-dependent shifts in the microbiome-endocrine-brain axis Open
Despite recent advances in understanding the connection between the gut microbiota and the adult brain, significant knowledge gaps remain regarding how gut inflammation affects brain development. We hypothesized that gut inflammation durin…
View article: High-Grade Gastrointestinal Neuroendocrine Carcinomas: Multidisciplinary Approach Can Improve Survival Outcomes
High-Grade Gastrointestinal Neuroendocrine Carcinomas: Multidisciplinary Approach Can Improve Survival Outcomes Open
Purpose There is limited evidence for the presentation patterns and outcomes of patients with high-grade gastrointestinal neuroendocrine carcinomas (HG-NEC). Methods Patients diagnosed with HG-NEC, defined as having a pathological diagnosi…
View article: Early-Life Gut Inflammation Drives Sex-Dependent Shifts in the Microbiome-Endocrine-Brain Axis
Early-Life Gut Inflammation Drives Sex-Dependent Shifts in the Microbiome-Endocrine-Brain Axis Open
Despite recent advances in understanding the connection between the gut microbiota and the adult brain, there remains a wide knowledge gap in how gut inflammation impacts brain development. We hypothesized that intestinal inflammation in e…
View article: Why oncology?
Why oncology? Open
I am not a writer and this is not my story but only a part of it. My answer to "Why oncology?" As I have lived my life, I have always been probed by myself and by others alike as to "why," why did I/you choose this, why did I/you do this a…
View article: INHIBITION OF HDAC3 DURING IMMUNE STIMULUS AMELIORATES SEX-SPECIFIC DEPRESSIVE-LIKE BEHAVIOUR AND ABERRANT MICROGLIAL MORPHOLOGY
INHIBITION OF HDAC3 DURING IMMUNE STIMULUS AMELIORATES SEX-SPECIFIC DEPRESSIVE-LIKE BEHAVIOUR AND ABERRANT MICROGLIAL MORPHOLOGY Open
View article: Nivolumab in platinum-refractory head-and-neck cancers: A retrospective observational audit from a tertiary cancer center
Nivolumab in platinum-refractory head-and-neck cancers: A retrospective observational audit from a tertiary cancer center Open
Background: Nivolumab and pembrolizumab are approved treatment options for platinum-refractory head-and-neck squamous cell cancer (HNSCC) based on the demonstration of improved outcomes in clinical trials. However, limited data exist on th…